Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used